Ingrid Hedenfalk (I Hedenfalk)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Nature communications

Cancers

Human reproduction (Oxford, England)

NPJ breast cancer

Lund University

Lund University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lund University

Sweden

Associate Professor :: Department of Clinical Sciences, Division of Oncology and Pathology

Education History

Lund University - Mar 01 2002

Sweden

PHD :: Department of Oncology

Publications

Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Anna Linder, S Westbom-Fremer, C Mateoiu, A Olsson Widjaja, Tobias Österlund, S Veerla, A Ståhlberg, Benjamin Ulfenborg, Ingrid Hedenfalk, Karin Sundfelt
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. Human reproduction (Oxford, England) 39 (5) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Anna Linder, S Westbom-Fremer, C Mateoiu, A Olsson Widjaja, Tobias Österlund, S Veerla, A Ståhlberg, Benjamin Ulfenborg, Ingrid Hedenfalk, Karin Sundfelt
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. Human reproduction (Oxford, England) 39 (5) (2024)
Anna Linder, S Westbom-Fremer, C Mateoiu, A Olsson Widjaja, Tobias Österlund, S Veerla, A Ståhlberg, Benjamin Ulfenborg, Ingrid Hedenfalk, Karin Sundfelt
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. Human reproduction (Oxford, England) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Anna Linder, S Westbom-Fremer, C Mateoiu, A Olsson Widjaja, Tobias Österlund, S Veerla, A Ståhlberg, Benjamin Ulfenborg, Ingrid Hedenfalk, Karin Sundfelt
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. Human reproduction (Oxford, England) 39 (5) (2024)
Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Oscar Briem, Eva Källberg, Siker Kimbung, Srinivas Veerla, Jenny Stenström, Thomas Hatschek, Catharina Hagerling, Ingrid Hedenfalk, Karin Leandersson
CD169 + Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T regs and a Worse Prognosis for Patients with Advanced Breast Cancer. Cancers 15 (4) (2023)
Oscar Briem, Eva Källberg, Siker Kimbung, Srinivas Veerla, Jenny Stenström, Thomas Hatschek, Catharina Hagerling, Ingrid Hedenfalk, Karin Leandersson
CD169 + Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T regs and a Worse Prognosis for Patients with Advanced Breast Cancer. Cancers 15 (4) (2023)
Oscar Briem, Eva Källberg, Siker Kimbung, Srinivas Veerla, Jenny Stenström, Thomas Hatschek, Catharina Hagerling, Ingrid Hedenfalk, Karin Leandersson
CD169 + Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T regs and a Worse Prognosis for Patients with Advanced Breast Cancer. Cancers 15 (4) (2023)
Hani Saghir, Srinivas Veerla, Martin Malmberg, Lisa Rydén, Anna Ehinger, Lao H Saal, Johan Vallon-Christersson, Åke Borg, Cecilia Hegardt, Christer Larsson, Alaa Haidar, Ingrid Hedenfalk, Niklas Loman, Siker Kimbung
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer. Cancers 14 (16) (2022)
Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H Saal, Siker Kimbung, Ingrid Hedenfalk, Tonje Lien, Therese Sørlie, Bjørn Naume, Hege Russnes, Rachel Marcone, Ayyakkannu Ayyanan, Cathrin Brisken, Rebecka R Malterling, Bengt Asking, Helena Olofsson, Henrik Lindman, Pär-Ola Bendahl, Anna Ehinger, Christer Larsson, Niklas Loman, Lisa Rydén, Martin Malmberg, Åke Borg, Johan Vallon-Christersson
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ breast cancer 8 (1) (2022)
Jenny-Maria Jönsson, Maria Bååth, Ida Björnheden, Irem Durmaz Sahin, Anna Måsbäck, Ingrid Hedenfalk
Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer. Cancers 13 (2) (2021)
Jane Bayani, Coralie Poncet, Cheryl Crozier, Anouk Neven, Tammy Piper, Carrie Cunningham, Monika Sobol, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Judith Fraser, Florentine Hilbers, Ingrid Hedenfalk, Larissa Korde, Barbro Linderholm, John W M Martens, Lavinia Middleton, Melissa P Murray, Catherine M Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Aleksandra Peric, Peggy Porter, Carolien Schröder, Isabel T Rubio, Kathryn J Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien van Deurzen, Elise van Leeuwen-Stok, Joanna Vermeij, Eric P Winer, Sharon H Giordano, Fatima Cardoso, Timothy J Whelan
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. NPJ breast cancer 7 (1) (2021)
Maria Bååth, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura Martín de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Gabriella Honeth, Ingrid Hedenfalk
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes 12 (5) (2021)
Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente, Anna Ebbesson, Juliette Davis, Susanne Malander, Anna Måsbäck, Päivi Kannisto, Ingrid Hedenfalk
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery. Molecular & cellular oncology 7 (6) (2020)
Nicolai Skovbjerg Arildsen, Laura Martin de la Fuente, Anna Måsbäck, Susanne Malander, Ola Forslund, Päivi Kannisto, Ingrid Hedenfalk
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method. Scientific reports 9 (1) (2019)
Malin Grönberg, Cecilia Nilsson, Ida Markholm, Ingrid Hedenfalk, Carl Blomqvist, Lars Holmberg, Eva Tiensuu Janson, Marie-Louise Fjällskog
Ghrelin expression is associated with a favorable outcome in male breast cancer. Scientific reports 8 (1) (2018)
Siker Kimbung, Ida Markholm, Judith Bjöhle, Tobias Lekberg, Anna von Wachenfeldt, Edward Azavedo, Ariel Saracco, Mats Hellström, Srinivas Veerla, Eric Paquet, Pär-Ola Bendahl, Mårten Fernö, Jonas Bergh, Niklas Loman, Thomas Hatschek, Ingrid Hedenfalk, null null
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial. International journal of cancer 142 (3) (2017)

Ingrid Hedenfalk (I Hedenfalk)

Publication Activity (10 Years)

Top Topics

Top Venues